Molecular Research on Drug Induced Liver Injury
Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, Frankfurt am Main, D-63450 Hanau, Germany
Pharmacovigilance Consultancy, 75020 Paris, France
Authors to whom correspondence should be addressed.
Received: 1 November 2017 / Revised: 8 December 2017 / Accepted: 9 January 2018 / Published: 11 January 2018
Note: In lieu of an abstract, this is an excerpt from the first page.
Drugs may cause liver injury in a few susceptible individuals, but the molecular events that lead to this idiosyncratic, largely dose-independent and non-predictable drug-induced liver injury (DILI) are mostly unknown, since animal models to explore the pathogenetic mechanisms of human idiosyncratic DILI are not yet reliable.[...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Teschke, R.; Danan, G. Molecular Research on Drug Induced Liver Injury. Int. J. Mol. Sci. 2018, 19, 216.
Teschke R, Danan G. Molecular Research on Drug Induced Liver Injury. International Journal of Molecular Sciences. 2018; 19(1):216.
Teschke, Rolf; Danan, Gaby. 2018. "Molecular Research on Drug Induced Liver Injury." Int. J. Mol. Sci. 19, no. 1: 216.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.